These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis. Abati E; Bresolin N; Comi G; Corti S Mol Neurobiol; 2019 Oct; 56(10):6703-6715. PubMed ID: 30911936 [TBL] [Abstract][Full Text] [Related]
17. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Mitsumoto H; Brooks BR; Silani V Lancet Neurol; 2014 Nov; 13(11):1127-1138. PubMed ID: 25316019 [TBL] [Abstract][Full Text] [Related]
18. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS). Haidet-Phillips AM; Maragakis NJ Brain Res; 2015 Dec; 1628(Pt B):343-350. PubMed ID: 26187754 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of human adipose-derived stem cells in neurological disorders. Chang KA; Lee JH; Suh YH J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope? Allers C; Jones JA; Lasala GP; Minguell JJ Regen Med; 2014; 9(5):637-47. PubMed ID: 25372079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]